Search

everythinglearnresearchcommunity

for

Search:↓

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Newer GLP-1 drugs like semaglutide may cause hair loss.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Blocking prolactin increases the activity of secondary hair follicles in cashmere goats.

Targeting the p300/AR axis may help treat polycystic ovary syndrome.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

Laser-assisted prostaglandin analogs improve hypopigmented scars safely, but more research is needed.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Enhanced stem cells from the placenta can reduce fat buildup in eye tissue for Graves' disease.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Padina arborescens and its component MOGG may help prevent hair loss through several actions, including blocking a hair loss-related enzyme.

Progesterone affects GABA_A receptor function by altering δ subunit levels.

A new treatment for hair loss shows promise with fewer side effects.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Activating androgen receptors in muscle can increase muscle mass and reduce fat.

Blocking androgen receptors early in life increases estrogen levels and reduces sexual motivation in male rats.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

Increased PPARGC1α relates to hair thinning in common baldness.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.